Molecule Details
| InChIKey | VRENQJJXDFBYMO-FAIXQHPJSA-N |
|---|---|
| Compound Name | 2-[4-[2-[3-[4-[4-[[2-[(2S)-2-(1,3-benzoxazole-2-carbonyl)pyrrolidin-1-yl]-2-oxoethyl]carbamoyl]quinolin-6-yl]phenyl]sulfonylpropylamino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid |
| Canonical SMILES | O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)NCCCS(=O)(=O)c2ccc(-c3ccc4nccc(C(=O)NCC(=O)N5CCC[C@H]5C(=O)c5nc6ccccc6o5)c4c3)cc2)CCN(CC(=O)O)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.3 |
| Source | BindingDB |
2D Structure
Activity Profile